Detailed Guide Regarding the EudraVigilance Data Management Activities by the EMA

On 9 November 2020 the EMA announced the availability of the updated guide.

This document provides an overview of the data management and quality assurance activities performed by the EMA on information of suspected adverse reactions and medicinal products reported to and held in EudraVigilance and the XEVMPD.

Read the pdf 
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /